Brief: Jenscare Scientific Announces Enrollment In Total Product Life Cycle Advisory Program Of U.S. FDA
18/09/2023 02:35
Sept 18 (Reuters) - Jenscare Scientific Co Ltd
9877.HK :
* TRANSCATHETER TRICUSPID VALVE REPLACEMENT SYSTEM PRODUCTS
ENROLLED IN TOTAL PRODUCT LIFE CYCLE ADVISORY PROGRAM OF U.S.
FDA
Further company coverage: 9877.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Jenscare Scientific Co
See all newsBrief: Jenscare Scientific Says Ken-Valve Transcatheter Aortic Valve Replacement System Receives HK Approval
Brief: Jenscare Scientific Posts FY Revenue Of RMB90.6 Million
Brief: Jenscare Scientific Appoints Li Yuanyuan As CFO
Brief: Jenscare Scientific Receives NZ Approval For Ken-Valve And Lux-Valve Plus
Brief: Jenscare Scientific Says Lux-Valve Plus Receives FDA IDE Approval For Pivotal Trial